ICON Launches New Drug Safety Reporting Solution that Ensures Compliance through Automation
DUBLIN--(BUSINESS WIRE)--Feb 5, 2019--ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device…
